Valutazione economica di treosulfan in pazienti sottoposti a trapianto allogenico di cellule staminali ematopoietiche

OBJECTIVE: To assess the cost-effectiveness and economic sustainability of treosulfan plus fludarabine compared with busulfan plus fludarabine as a conditioning treatment for malignant disease prior to allogeneic haematopoietic stem cell transplantation (alloHSCT) in adult patients in Italy. METHOD:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bini, Chiara, Paoletti, Martina, Marcellusi, Andrea, Tomino, Carlo, Mennini, Francesco Saverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768594/
https://www.ncbi.nlm.nih.gov/pubmed/36628308
http://dx.doi.org/10.33393/grhta.2022.2412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768594/
https://www.ncbi.nlm.nih.gov/pubmed/36628308
http://dx.doi.org/10.33393/grhta.2022.2412

Ejemplares similares